M. Joly

发表

Effects of Recombinant Growth Factors on Energy Expenditure in Maintenance Hemodialysis Patients

M. Laville, A. Tabakian, L. Juillard, 1998, Mineral and Electrolyte Metabolism.

Intensity‐dependent constitutional MLH1 promoter methylation leads to early onset of colorectal cancer by affecting both alleles

Z. Herceg, J. Saurin, A. Puisieux, 2011, Genes, chromosomes & cancer.

Acute leptin regulation in end-stage renal failure: the role of growth hormone and IGF-1.

M. Laville, A. Tabakian, L. Juillard, 1998, Kidney international.

Haemodialysis with the biocompatible high permeability AN-69 membrane does not alter plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3.

M. Joly, M. Laville, D. Fouque, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Characteristics of H3 K27M-mutant gliomas in adults

F. Ducray, J. Honnorat, A. Jouvet, 2017, Neuro-oncology.

O6-Methylguanine-DNA methyltransferase status in neuroendocrine tumours: prognostic relevance and association with response to alkylating agents

V. Hervieu, J. Scoazec, C. Vercherat, 2015, British Journal of Cancer.

Gemcitabine and oxaliplatin or alkylating agents for neuroendocrine tumors: Comparison of efficacy and search for predictive factors guiding treatment choice

V. Hervieu, J. Scoazec, C. Vercherat, 2015, Cancer.

A SDHB malignant paraganglioma with dramatic response to temozolomide-capecitabine.

J. Scoazec, C. Lombard-Bohas, F. Borson‐Chazot, 2012, European journal of endocrinology.

Serum interleukin-6 levels in adult acute myelogenous leukemia: relationship with disease characteristics and outcome.

X. Thomas, E. Archimbaud, M. Joly, 1997, Leukemia & lymphoma.

The axon guidance molecule semaphorin 3F is a negative regulator of tumor progression and proliferation in ileal neuroendocrine tumors

V. Hervieu, J. Scoazec, C. Vercherat, 2015, Oncotarget.

Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation

J. Saurin, A. Puisieux, Qing Wang, 2007, Human mutation.

Combination chemotherapy with 5-fluorouracil and dacarbazine in advanced medullary thyroid cancer, a possible alternative?

F. Borson‐Chazot, M. Joly, C. Bournaud, 2016, Acta oncologica.

p.Ala541Thr variant of MEN1 gene: a non deleterious polymorphism or a pathogenic mutation?

V. Hervieu, P. Ruszniewski, F. Borson‐Chazot, 2014, Annales d'endocrinologie.

Assay of Growth Hormone Levels in Human Plasma using Commercial Kits: Analysis of Some Factors Influencing the Results

G. Sassolas, J. Souberbielle, P. Chatelain, 1990, Acta paediatrica Scandinavica. Supplement.

A case report of Muir-Torre syndrome in a woman with breast cancer and MSI-Low skin squamous cell carcinoma

R. Schiappa, C. Lepage, L. Faivre, 2017, Hereditary Cancer in Clinical Practice.

Identification of newborns with Fetal Growth Restriction (FGR) in weight and/or length based on constitutional growth potential

M. Joly, B. Rousset, G. Mellier, 2006, European Journal of Pediatrics.

Heterogeneity of human prolactin. Influence on immunoassays (RIA and IRMA).

M. Joly, B. Claustrat, J. Brun, 1994, Nuclear medicine and biology.

Perfusion of human term placenta in situ with C-19 and C-18 steroids.

M. Joly, Y. Lefebvre, E. Bolté, 1969, Acta endocrinologica.

Somatic MMR Gene Mutations as a Cause for MSI‐H Sebaceous Neoplasms in Muir–Torre Syndrome‐Like Patients

J. Saurin, C. Audoynaud, Qing Wang, 2015, Human mutation.

[Role of interleukin 6 in the edema phase of patients with severe burns].

M. Joly, P. Gueugniaud, M. Bertin-Maghit, 1993, Presse medicale.

Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial

F. Ducray, M. Sanson, O. Chinot, 2016, Oncotarget.

The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death commitment

Giovanni Romeo, Jean-Christophe Saurin, Jean-Yves Scoazec, 2003, Proceedings of the National Academy of Sciences of the United States of America.

EXPRESSION OF MENIN IN THE HUMAN THYROID GLAND.

F. Borson‐Chazot, M. Joly, M. Decaussin-Petrucci, 2017, Acta endocrinologica.

Insulin-like growth factor-1 and its binding proteins during a low-protein diet in chronic renal failure.

Y. Le Bouc, M. Joly, M. Laville, 1995, Journal of the American Society of Nephrology : JASN.

A case report of Muir-Torre syndrome in a woman with breast cancer and MSI-Low skin squamous cell carcinoma

R. Schiappa, C. Lepage, L. Faivre, 2017, Hereditary cancer in clinical practice.

Increase of circulating insulin-like growth factor-I in chronic renal failure is reduced by low-protein diet.

B. Beaufrère, P. Chatelain, M. Joly, 1992, Mineral and electrolyte metabolism.

[Cerebellar gangliocytoma in an 11-year-old child].

A. Jouvet, M. Joly, A. Vasiljevic, 2014, Annales de pathologie.

MLH1 promoter hypermethylation: are you absolutely sure about the absence of MLH1 germline mutation? About a new case

R. Schiappa, Qing Wang, M. Joly, 2019, Familial Cancer.